Online

Family Medicine

Search

Filter Content

Page 4 of 4

Results 226 - 281 of 281

Optimizing Management of IPF

How Would You Manage President Theodore Roosevelt’s Asthma Today?

Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child

2019 Summer Pulmonary Updates: The Experts Weigh In

A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story

How Pulmonary Arterial Hypertension Has Changed Iain’s Life

Biosimilars: Applying the Science to Hematology/Oncology Practice

atopic-derm2 copy

Atopic Dermatitis: Recent and Emerging Therapies

An Introduction to Atopic Dermatitis

PAH Today: Mastering Current, Tailored Treatment

Achieving Better Control of Severe Asthma

asthma-uncontrol icon

A Personalized Approach to Managing Uncontrolled Asthma

biosims-archmed icon23

Top Questions about Biosimilars in Dermatology

biosims-archmed icon1

Top Questions about Biosimilars in Gastroenterology

biosims-archmed icon2

Top Questions about Biosimilars in Rheumatology

biosims-archmed icon

Top Questions about Biosimilars in Hematology/Oncology

biosims-gastro2

Biosimilars and Patients with Inflammatory Bowel Disease

biosims-gastro1

Biosimilars: The New Era of Gastroenterology Management Considerations

psoriasis-nurse

Psoriasis Management Considerations: What Would You Do?

psoriasis-case3

Jamie Develops Complications with Her Psoriasis

psoriasis-case2

Psoriasis: Three Case Studies in the Primary Care Setting

psoriasis-case1

Cindy Has a Complex Case of Psoriasis

Famous People with Diabetes: Ella Fitzgerald

Famous People with Diabetes: Jerry Garcia

Targeting B-cells in Primary Progressive MS (PPMS)

Comorbidities and Selection of DMTs

The Gut Microbiota in MS

Early MS: Induction Therapy and Escalation Strategies

Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS

t2diabetes-slides1

Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options

t2diabetes-slides2

Download Slides: Advancing T2DM Therapy with Confidence

t2diabetes-louise

Getting to Goal Can Be Difficult: Louise

t2diabetes-brian

Getting to Goal Can Be Difficult: Brian

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

IL-gastro-case3

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

IL-gastro-case2

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

IL-gastro-case1

Innovator or Biosimilar for a Patient with Ulcerative Colitis?

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Innovator or Biosimilar for a Patient with Psoriasis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Are You Ready to Use Biosimilars in Your Practice?

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Addressing Common Barriers to Adherence

Page 4 of 4